Preferred Label : Attenuation of GPCR Signaling Pathway;
NCIt related terms : Attenuation of GPCR Signaling;
Alternative definition : BIOCARTA: The G-protein coupled receptor (GPCR) family transduces extracellular signals
across the plasma membrane, activating cellular responses through a variety of second
messenger cascades (see PKA and PKC signaling pathways). These receptors provide rapid
responses to a variety of stimuli, and are often rapidly attenuated in their signaling.
Failure to attenuate GPCR signaling can have dramatic consequences. One method to
attenuate GPCR signaling is by removal of the stimulus from the extracellular fluid.
At the synapse, removal of neurotransmitter or peptide signaling molecules is accomplished
by either reuptake or degradation. Acetylcholine is removed from synapses through
degradation by the enzyme acetylcholinesterase. Inhibition of acetylcholinesterase
results in prolonged signaling at the neuromuscular junction, and uncontrollable spasms
in humans caused by nerve gas or in insects by some insecticides. Inhibition of acetylcholinesterase
is also used therapeutically to treat Alzheimer's disease, compensating for the loss
of cholinergic neurons. Transporters for serotonin, dopamine, GABA and noradrenaline
remove these neurotransmitters from the synapse to terminate signaling. Antidepressants
such as Prozac inhibit reuptake of serotonin and many drugs of abuse such as cocaine
act by blocking reuptake of dopamine or adrenaline. Reuptake not only terminates signaling,
but can also conserve neurotransmitter through recycling back into the presynaptic
cell. The next step in the attenuation of GPCR signaling is receptor desensitization,
in which receptors are modified to no longer transduce a signal even if the stimulus
is still present. Desensitization of GPCRs occurs through protein kinases that phosphorylate
the GPCR to turn off signaling. Downstream protein kinases such as PKA and PKC turned
on by GPCR signaling can phosphorylate the activated GPCR and other GPCRs to prevent
further signaling. G-protein receptor kinases (GRKs) are a family of kinases that
specifically phosphorylate only agonist-occupied GPCRs. GRKs attenuate GPCR signaling
in concert with arrestins, proteins that bind GRK-phosphorylated GPCRs to disrupt
interaction with G-protein and to terminate signaling. Reducing the number of receptor
expressed on the cell surface can also attenuate receptor signaling. Many GPCRs are
removed from the cell surface by receptor-mediated endocytosis when they are activated.
Endocytosis of activated GPCRs appears to be stimulated by GRKs and arrestins. Once
internalized, receptors can either be degraded in lysosomes or they can be recycled
back to the cell surface. (This definition may be outdated - see the DesignNote.);
NCIt note : The BIOCARTA Definition (ALT_DEFINITION) for this pathway concept was provided by
BioCarta. This property was not created by, nor is it maintained by the NCI Thesaurus
staff. Additionally, BioCarta is no longer updating its pathway data; thus, the BIOCARTA
Definition might be outdated or inaccurate. Please see the Terms and Conditions for
Use at http://www.biocarta.com/.;
Biocarta ID : h_agpcrPathway;
Origin ID : C38974;
UMLS CUI : C1516087;
Semantic type(s)
has_gene_product_element
pathway_has_gene_element